Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis

被引:3
|
作者
Bai, Zhaohui [1 ,2 ]
Xu, Wentao [1 ,2 ]
Chai, Lu [1 ,2 ]
Zheng, Xiaojie [1 ]
Mendez-Sanchez, Nahum [3 ]
Philips, Cyriac Abby [4 ]
Cheng, Gang [2 ]
Qi, Xingshun [1 ,2 ]
机构
[1] Gen Hosp Northern Theater Command, Dept Gastroenterol, Liver Cirrhosis Study Grp, Shenyang 110840, Peoples R China
[2] Shenyang Pharmaceut Univ, NMPA Key Lab Res & Evaluat Drug Regulatory Techno, Shenyang 110016, Peoples R China
[3] Univ Nacl Autonoma Mexico, Med Sur Clin, Mexico City 14050, DF, Mexico
[4] Rajagiri Hosp, Ctr Excellence GI Sci, Liver Inst, Clin & Translat Hepatol, Aluva 683112, India
关键词
liver cirrhosis; hyponatremia; human albumin; prevention; treatment; QUALITY-OF-LIFE; SYSTEMIC INFLAMMATION; ASCITES; MANAGEMENT; MORTALITY; COMPLICATIONS; ASSOCIATION; GUIDELINES;
D O I
10.3390/jcm12010107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and June 2014 were included in the Hospitalization outcome cohort, and 339 cirrhotic patients without malignancy who were consecutively admitted to our department between December 2014 and April 2021 were included in the Long-term outcome cohort. The development and improvement of hyponatremia were compared between patients who received HA infusion during hospitalizations and did not. Logistic and Cox regression analyses were performed to evaluate the association of development and improvement of hyponatremia during hospitalizations with the outcomes. Odds ratios (ORs) and hazard ratios (HRs) were calculated. Results: In the two cohorts, HA infusion significantly decreased the incidence of hyponatremia and increased the rate of improvement of hyponatremia in cirrhotic patients during hospitalizations. In the Hospitalization outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with increased in-hospital mortality (OR = 2.493, p < 0.001), and the improvement of hyponatremia during hospitalizations was significantly associated with decreased in-hospital mortality (OR = 0.599, p = 0.014). In the Long-term outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with decreased long-term survival (HR = 0.400, p < 0.001), and the improvement of hyponatremia during hospitalizations was not significantly associated with long-term survival (HR = 1.085, p = 0.813). Conclusions: HA infusion can effectively prevent the development of hyponatremia and improve hyponatremia in cirrhotic patients during hospitalizations, which may influence the patients' outcomes.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
    Bai, Zhaohui
    Wang, Le
    Lin, Hanyang
    Tacke, Frank
    Cheng, Gang
    Qi, Xingshun
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [2] SHORT-TERM TOLBUTAMIDE EFFECT ON PATIENTS WITH LIVER CIRRHOSIS
    HIRAYAMA, C
    KAWASAKI, H
    ARIMURA, K
    AMAGASE, H
    ACTA HEPATO-GASTROENTEROLOGICA, 1974, 21 (01): : 34 - 40
  • [3] Short-term effects of splenectomy on serum fibrosis indexes in liver cirrhosis patients
    Kong, Degang
    Chen, Xiuli
    Lu, Shichun
    Guo, Qingliang
    Lai, Wei
    Wu, Jushan
    Lin, Dongdong
    Zeng, Daobing
    Duan, Binwei
    Jiang, Tao
    Cao, Jilei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 15260 - 15264
  • [4] SHORT-TERM CARDIOVASCULAR EFFECTS OF SOMATOSTATIN IN PATIENTS WITH CIRRHOSIS
    GAUDIN, C
    MOREAU, R
    CHAMPIGNEULLE, B
    SOUBRANE, O
    KLEBER, G
    LEBREC, D
    LIVER, 1995, 15 (05): : 236 - 241
  • [5] Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
    Kaps, Leonard
    Lukac, Lejla
    Michel, Maurice
    Kremer, Wolfgang Maximilian
    Hilscher, Max
    Gairing, Simon Johannes
    Galle, Peter R.
    Schattenberg, Joern M.
    Woerns, Marcus-Alexander
    Nagel, Michael
    Labenz, Christian
    DIAGNOSTICS, 2022, 12 (05)
  • [6] Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
    Bai, Zhaohui
    Cheng, Gang
    Mendez-Sanchez, Nahum
    Qi, Xingshun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (14)
  • [7] Short-Term Outcomes of Minimally Invasive Esophagectomy for Carcinoma In Patients with Liver Cirrhosis
    Sozzi, Marco
    Siboni, Stefano
    Asti, Emanuele
    Bonitta, Gianluca
    Bonavina, Luigi
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2017, 27 (06): : 592 - 596
  • [8] Unveiling the Impact of Sarcopenia on Short-term Mortality in Hospitalized Liver Cirrhosis Patients
    Merli, Manuela
    Khan, Saniya
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (06) : 931 - 933
  • [9] METABOLIC EFFECTS OF SHORT-TERM INFUSION OF INTRALIPID
    UNTRACHT, SH
    CHUNG, J
    SCANU, AM
    CLINICAL RESEARCH, 1979, 27 (02): : A444 - A444
  • [10] AN EVALUATION OF HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER
    FALOON, WW
    ECKHARDT, RD
    MURPHY, TL
    COOPER, AM
    DAVIDSON, CS
    JOURNAL OF CLINICAL INVESTIGATION, 1949, 28 (04): : 583 - 594